DE809505T1 - Verfahren zur behandlung chronischer fortschreitender gefässerkrankungen - Google Patents

Verfahren zur behandlung chronischer fortschreitender gefässerkrankungen

Info

Publication number
DE809505T1
DE809505T1 DE0809505T DE96917917T DE809505T1 DE 809505 T1 DE809505 T1 DE 809505T1 DE 0809505 T DE0809505 T DE 0809505T DE 96917917 T DE96917917 T DE 96917917T DE 809505 T1 DE809505 T1 DE 809505T1
Authority
DE
Germany
Prior art keywords
vascular diseases
treating chronic
chronic progressive
progressive vascular
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE0809505T
Other languages
English (en)
Inventor
Gary E Striker
Liliane J Striker
Fred P Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Teva Branded Pharmaceutical Products R&D Inc
Original Assignee
US Department of Health and Human Services
Baker Cummins Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, Baker Cummins Pharmaceuticals Inc filed Critical US Department of Health and Human Services
Publication of DE809505T1 publication Critical patent/DE809505T1/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE0809505T 1995-06-07 1996-06-03 Verfahren zur behandlung chronischer fortschreitender gefässerkrankungen Pending DE809505T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/478,347 US5643892A (en) 1995-06-07 1995-06-07 Method of treating chronic progressive vascular diseases
PCT/US1996/008367 WO1996040158A1 (en) 1995-06-07 1996-06-03 Method of treating chronic progressive vascular diseases
BR9704114-9A BR9704114A (pt) 1995-06-07 1997-07-28 Processo de tratamento de doenças vasculares progressivas crÈnicas

Publications (1)

Publication Number Publication Date
DE809505T1 true DE809505T1 (de) 1998-05-28

Family

ID=25664870

Family Applications (1)

Application Number Title Priority Date Filing Date
DE0809505T Pending DE809505T1 (de) 1995-06-07 1996-06-03 Verfahren zur behandlung chronischer fortschreitender gefässerkrankungen

Country Status (14)

Country Link
US (1) US5643892A (de)
EP (1) EP0809505B1 (de)
AU (1) AU699012B2 (de)
BR (1) BR9704114A (de)
CA (1) CA2210351C (de)
DE (1) DE809505T1 (de)
ES (1) ES2115571T3 (de)
HU (1) HUP9802431A3 (de)
IL (1) IL121217A (de)
NO (1) NO313686B1 (de)
NZ (1) NZ309991A (de)
TW (1) TW434018B (de)
WO (1) WO1996040158A1 (de)
ZA (1) ZA964247B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010005720A1 (en) * 1995-06-07 2001-06-28 U.S.A. As Represented By The Secretary Department Of Health And Human Services Method of treating chronic progressive vascular scarring diseases
US6255295B1 (en) 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
UA65587C2 (en) 1997-10-09 2004-04-15 Baker Norton Pharma Method for preventing nephrotoxicity induced by cyclosporins or tacrolimus
DE19747195A1 (de) * 1997-10-24 1999-04-29 Knoll Ag Verwendung von Glykosaminoglykanen zur Herstellung von pharmazeutischen Zubereitungen zur Behandlung von mit Diabetes assoziierten Augenkrankheiten
AU2001230994A1 (en) 2000-01-19 2001-07-31 The United States of America, represented by The Secretary, Department of Health & Human Services Use of pentosan polysulfate to treat certain conditions of the prostate
CA2616230A1 (en) * 2005-07-22 2007-02-01 Trf Pharma, Inc. Method for treating sickle cell disease and sickle cell disease sequelae
PT2010220T (pt) * 2006-04-03 2022-05-20 Ceva Animal Health Pty Ltd Formulações de polisulfato de pentosano estabilizado (pps)
US9339524B2 (en) 2009-03-11 2016-05-17 Jellice Co., Ltd. Drug inhibiting the progression of atherosclerosis, preventive drug, blood cholesterol-lowering drug, functional food, and specific health food
WO2011088418A2 (en) * 2010-01-15 2011-07-21 Mount Sinai School Of Medicine Inhibition of tnf-alpha induced activation of nfkb by pentosan polysulfate
CN103764824B (zh) 2011-06-20 2018-04-24 西奈山医学院 粘多糖贮积症和其它溶酶体病症的抗TNF-α疗法
US20130273096A1 (en) * 2011-10-05 2013-10-17 Bruce A. Daniels Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients
EP3842048A4 (de) 2018-08-20 2022-03-30 ReqMed Company, Ltd. Neuartiges pentosanpolysulfatpräparat

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4966890A (en) * 1986-04-04 1990-10-30 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
DE3725554A1 (de) * 1987-08-01 1989-02-09 Hoechst Ag Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung
US5032679A (en) * 1988-12-15 1991-07-16 Glycomed, Inc. Heparin fragments as inhibitors of smooth muscle cell proliferation
EP0466315A3 (en) * 1990-05-30 1992-07-01 Larrian Gillespie Compositions containing xylan sulphates for affecting growth factor function and for inhibiting fibroblast proliferation
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate

Also Published As

Publication number Publication date
CA2210351C (en) 2003-09-23
IL121217A0 (en) 1999-10-28
AU699012B2 (en) 1998-11-19
WO1996040158A1 (en) 1996-12-19
TW434018B (en) 2001-05-16
EP0809505A1 (de) 1997-12-03
NO973081D0 (no) 1997-07-02
HUP9802431A3 (en) 2001-06-28
ZA964247B (en) 1996-12-04
HUP9802431A2 (hu) 1999-02-01
NZ309991A (en) 2001-03-30
ES2115571T1 (es) 1998-07-01
NO313686B1 (no) 2002-11-18
EP0809505B1 (de) 2003-04-02
IL121217A (en) 2000-09-28
US5643892A (en) 1997-07-01
EP0809505A4 (de) 1998-07-01
CA2210351A1 (en) 1996-12-19
BR9704114A (pt) 2000-06-06
NO973081L (no) 1997-08-27
AU6030096A (en) 1996-12-30
ES2115571T3 (es) 2003-09-01

Similar Documents

Publication Publication Date Title
DE69218202T2 (de) Verfahren zur behandlung von fluoroaluminosilikatgläsern
ATE225185T1 (de) Verfahren zur behandlung von allergischem asthma
DE69603838T2 (de) Verfahren zur behandlung von gasen
DE69503623D1 (de) Verbessertes verfahren zur kathetersegment-befestigung
DE60042611D1 (de) Verfahren zur behandlung von gefässerkrankungen, dxid auszeichnen
DE69603277T2 (de) Verfahren zur plasma aktivierten wärmebehandlung von titannitrid
DE69425372D1 (de) Verfahren zur behandlung endo-ostealer materialien
DE69611417D1 (de) Verfahren zur Begasungsbodenbehandlung
DE69534701D1 (de) Verfahren zur behandlung von entzündlichen gelenkerkrankungen
DE69526796T2 (de) Verfahren zur inhibierung von pflanzenkrankheiten
DE809505T1 (de) Verfahren zur behandlung chronischer fortschreitender gefässerkrankungen
DE69518824T2 (de) Verfahren zur behandlung von bremsscheiben
DE69838226D1 (de) Verfahren zur plasmabehandlung
DE69936994D1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
DE69607559D1 (de) Verfahren zur Behandlung von Phenolteer
DE69609082D1 (de) Verfahren zur behandlung von abfällen
DE69601540T2 (de) Verfahren zur oxychlorierung
DE69307803D1 (de) Verfahren zur elektrolytischen Behandlung
DE69609963D1 (de) Verfahren zur iodierung
DE69905263D1 (de) Verfahren zur dekorativen behandlung von oberflächen
DE69701726D1 (de) Verfahren zur behandlung von knitterempfindlichen geweben
DE69310509D1 (de) Verfahren zur behandlung von kartoffelsäften
ATE209861T1 (de) Verfahren zur behandlung von gefrorenen blattgemüse-portionen
DE69311802T2 (de) Verfahren zur metallbehandlung
DE69427897T2 (de) Verfahren zur Behandlung von kontaminierten Sedimenten